CervoMed Inc.
CRVO
$4.19
-$0.05-1.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.70K | 322.60K | 1.76M | 1.92M | 2.16M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.70K | 322.60K | 1.76M | 1.92M | 2.16M |
| Cost of Revenue | 5.83M | 6.04M | 5.11M | 4.84M | 7.09M |
| Gross Profit | -5.82M | -5.72M | -3.35M | -2.92M | -4.92M |
| SG&A Expenses | 2.51M | 2.33M | 3.27M | 2.38M | 2.32M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.34M | 8.37M | 8.37M | 7.22M | 9.40M |
| Operating Income | -8.33M | -8.04M | -6.62M | -5.30M | -7.24M |
| Income Before Tax | -8.09M | -7.73M | -6.26M | -4.89M | -6.71M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.09M | -7.73M | -6.26M | -4.89M | -6.71M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.09M | -7.73M | -6.26M | -4.89M | -6.71M |
| EBIT | -8.33M | -8.04M | -6.62M | -5.30M | -7.24M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.87 | -0.84 | -0.70 | -0.56 | -0.77 |
| Normalized Basic EPS | -0.55 | -0.52 | -0.44 | -0.35 | -0.48 |
| EPS Diluted | -0.87 | -0.84 | -0.70 | -0.56 | -0.77 |
| Normalized Diluted EPS | -0.55 | -0.52 | -0.44 | -0.35 | -0.48 |
| Average Basic Shares Outstanding | 9.26M | 9.25M | 8.95M | 8.70M | 8.71M |
| Average Diluted Shares Outstanding | 9.26M | 9.25M | 8.95M | 8.70M | 8.71M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |